# Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data

> **NCT04818151** · — · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 14914 (actual)

## Conditions studied

- Venous Thromboembolic Disease
- Kidney Failure, Chronic

## Interventions

- **DRUG:** Warfarin
- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT04818151
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 14914 (ACTUAL)
- **Last updated:** 2021-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818151, "Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04818151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*